2 Patents
- US123207932025Analysis Method of 3-methyl-1-phenyl-2-pyrazolin-5-one Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-methyl-1-phenyl-2-pyrazolin-5-one Active Pharmaceutical Ingredient
MITSUBISHI TANABE PHARMA CORPORATION
0 cites - US117402192023Analysis Method of 3-methyl-1-phenyl-2-pyrazolin-5-one Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-methyl-1-phenyl-2-pyrazolin-5-one Active Pharmaceutical Ingredient
MITSUBISHI TANABE PHARMA CORPORATION
0 cites